Drug
GH21 clinical trials
Also written GH21.
- studies test it
- 3
- open now
- 3
- in phase 3
- 0
- first study started
- 2022
Keep track of what changes. Save the GH21 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- GH21
- 2
Studies by the year they started
3 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Suzhou Genhouse Bio Co., Ltd. (3)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses GH21 is read from its arms, and is right about nine times in ten.
Testing it · 3
- GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early ResultsRecruitingPhase 1Suzhou Genhouse Bio Co., Ltd.NCT05183243Written as GH21 Capsule
- GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid TumorsNot yet recruitingPhase 1/2Suzhou Genhouse Bio Co., Ltd.NCT06435455Written as GH21
- A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLCRecruitingPhase 1/2Suzhou Genhouse Bio Co., Ltd.NCT06306456Written as GH21